Virbagen DHA2PPi/L

CAV 2 tulpina Manhattan, CDV tulpina Lederle, CPV tulpina CPV 780916, CPIV tulpina Manhattan, L. interrogans, serogrup canicola, L. interrogans, serogrup icterohaemorrhagiae

Product information

Trade name: Virbagen DHA2PPi/L

Active substance: CAV 2 tulpina Manhattan, CDV tulpina Lederle, CPV tulpina CPV 780916, CPIV tulpina Manhattan, L. interrogans, serogrup canicola, L. interrogans, serogrup icterohaemorrhagiae

Therapeutic group: Organic products

Pharmaceutical form: suspensie injectabilă

Presentation: flacon x 1 doză

Target species: dogs

Therapeutic action: Caini Imunoprofilaxia parvovirozei, bolii Carre, hepatitei infectioase, parainfluentei si leptospirozei.

Waiting period: Nu este cazul.

Release mode: Cu prescripţie

Authorization data

Authorization number: 220014

Authorization status: Valida

Date of issue of the authorization: 20-01-2022

Authorization valid until: nelimitata

Manufacturer / Serial Release Company: VIRBAC S.A., Franţa

Licensee: VIRBAC S.A., Franţa

Responsible company in Romania: ALTIUS SA

Remarks: Autorizaţie de Comercializare emisă în urma unui transfer de autorizaţie.